Facebook Linkedin Twitter
Inside Precision Medicine Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Antibody immunotherapy

Immune checkpoint inhibitors: Interaction between PD-1 (blue) on a T-cell and PD-L1 (red) on a cancer cell blocked by therapeutic antibodies
News & Features

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

0
Mitochondria - microbiology
News & Features

Mitochondrial-Targeted Gene Therapy Disables Cancer’s Power in Mice

0
Microscopic view of bone marrow slide showing Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
News & Features

Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma Patients

0
Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
News & Features

Mantle Cell Lymphoma Patients May Not Need Stem Cell Transplant

0
Glioblastoma brain cancer, CT scan
News & Features

New Trispecific Antibody Immunotherapy Shows Promise for Treating Glioblastoma

0
Asked & Answered column photo
News & Features

Breaking New Ground in Immunology & Inflammation

Damian Doherty
0
Ulcerative Colitis Pains
News & Features

Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative Colitis

0
Pancreatic Cancer Concept
News & Features

Bringing Radioimmunotherapy to Solid Tumors

0
Conceptual image of a multiple sclerosis (MS) neuron.
News & Features

MS Disability Reduced by Starting Antibody Therapy Early

0
Alzheimer's disease: illustration of the amyloid-beta 40 peptide (and others) accumulating to form amyloid fibrils that build up dense amyloid plaques.
News & Features

Alzheimer’s Drug Effects May Be Linked to Increased Brain Protein Levels, Not Reduced Amyloid Plaque

0
123...7Page 1 of 7

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine